[go: up one dir, main page]

SG11202101881UA - Process for preparing vaccine compositions - Google Patents

Process for preparing vaccine compositions

Info

Publication number
SG11202101881UA
SG11202101881UA SG11202101881UA SG11202101881UA SG11202101881UA SG 11202101881U A SG11202101881U A SG 11202101881UA SG 11202101881U A SG11202101881U A SG 11202101881UA SG 11202101881U A SG11202101881U A SG 11202101881UA SG 11202101881U A SG11202101881U A SG 11202101881UA
Authority
SG
Singapore
Prior art keywords
vaccine compositions
preparing vaccine
preparing
compositions
vaccine
Prior art date
Application number
SG11202101881UA
Inventor
Julianna Liszewicz
Levente Molnár
Eniko Toke
József Toth
Orsolya Lorincz
Zsolt Csiszovszki
Eszter Somogyi
Katalin Pántya
Mónika Megyesi
Péter Páles
Original Assignee
Treos Bio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Treos Bio Ltd filed Critical Treos Bio Ltd
Publication of SG11202101881UA publication Critical patent/SG11202101881UA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001102—Receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2818—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2827—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against B7 molecules, e.g. CD80, CD86
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11202101881UA 2018-09-04 2019-09-03 Process for preparing vaccine compositions SG11202101881UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1814362.8A GB201814362D0 (en) 2018-09-04 2018-09-04 Composition and process for preparing vaccine
PCT/EP2019/073481 WO2020048995A1 (en) 2018-09-04 2019-09-03 Process for preparing vaccine compositions

Publications (1)

Publication Number Publication Date
SG11202101881UA true SG11202101881UA (en) 2021-03-30

Family

ID=63920945

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202101881UA SG11202101881UA (en) 2018-09-04 2019-09-03 Process for preparing vaccine compositions

Country Status (17)

Country Link
US (3) US20200069786A1 (en)
EP (1) EP3847185A1 (en)
JP (2) JP2021535749A (en)
KR (1) KR20210086610A (en)
CN (1) CN113383009A (en)
AU (1) AU2019334261B2 (en)
BR (1) BR112021004075A2 (en)
CA (1) CA3110923A1 (en)
CL (1) CL2021000534A1 (en)
CO (1) CO2021004028A2 (en)
EA (1) EA202190669A1 (en)
GB (1) GB201814362D0 (en)
IL (1) IL281220A (en)
MA (1) MA53544A (en)
MX (1) MX2021002543A (en)
SG (1) SG11202101881UA (en)
WO (1) WO2020048995A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3054871A1 (en) 2017-03-03 2018-09-07 Treos Bio Zrt Population-based immunogenic peptide identification platform
GB201804468D0 (en) * 2018-03-21 2018-05-02 Valo Therapeutics Oy PeptiCRAd Cancer Therapy
TW202016131A (en) * 2018-05-16 2020-05-01 德商英麥提克生物技術股份有限公司 Peptides for use in immunotherapy against cancers
KR20210086612A (en) 2018-09-04 2021-07-08 트레오스 바이오 리미티드 peptide vaccine
BR112022001697A2 (en) * 2019-07-30 2022-06-07 Univ Health Network T cell receptors and methods of using them
GB202004974D0 (en) 2020-04-03 2020-05-20 Treos Bio Ltd Coronavirus vaccine
WO2021243295A2 (en) * 2020-05-29 2021-12-02 Children's National Medical Center Identification of hla-restricted prame peptide epitopes, prame-specific t cells suitable for "off-the-shelf" treatment of cancer expressing prame
CN111617238B (en) * 2020-06-02 2022-12-13 苏州药明康德新药开发有限公司 Polypeptide vaccine preparation for treating tumor of mouse CT26 colorectal cancer and preparation method thereof
EP3945320A1 (en) * 2020-07-29 2022-02-02 Corporació Sanitària Parc Taulí Improved epitope for detecting and/or quantifying autoantibodies against alpha-fetoprotein
US20240228536A1 (en) * 2020-10-28 2024-07-11 Follicum Ab Peptides for use in skin and hair pigmentation
EP4323379A4 (en) * 2021-04-14 2025-12-17 Tscan Therapeutics Inc MAGEC2 IMMUNOGENEOUS PEPTIDES, MAGEC2 IMMUNOGENEOUS PEPTIDE BINDING PROTEINS AND THEIR USES
CN113144181B (en) * 2021-04-20 2022-07-19 徐州医科大学 B7H 3-targeted DNA vaccine, and preparation method and application thereof
CN114195861A (en) * 2022-01-05 2022-03-18 许昌学院 Affinity peptide
CN115785211B (en) * 2022-06-10 2024-09-24 河北博海生物工程开发有限公司 Lung cancer specific molecular target 04 and application thereof
CN115785204B (en) * 2022-06-10 2024-02-13 河北博海生物工程开发有限公司 Lung cancer specific molecular target 08 and application thereof
WO2025227519A1 (en) * 2024-04-29 2025-11-06 北京臻知医学科技有限责任公司 Tumor vaccine and use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235877A (en) 1979-06-27 1980-11-25 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
FR2791895B1 (en) 1999-03-23 2001-06-15 Pasteur Merieux Serums Vacc USE OF TREHALOSE TO STABILIZE A LIQUID VACCINE
AUPQ776100A0 (en) * 2000-05-26 2000-06-15 Australian National University, The Synthetic molecules and uses therefor
GB0520067D0 (en) * 2005-10-01 2005-11-09 Cancer Rec Tech Ltd Treatment of cancer
US9487574B2 (en) * 2006-09-21 2016-11-08 Vaxil Biotherapeutics Ltd. Antigen specific multi epitope vaccines
GB201004575D0 (en) * 2010-03-19 2010-05-05 Immatics Biotechnologies Gmbh Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers
WO2012051282A2 (en) * 2010-10-14 2012-04-19 The Ohio State University Research Foundation Piwil2-like (pl2l) proteins-targeted cancer diagnosis and therapy
GB201315946D0 (en) * 2013-09-06 2013-10-23 Immune Targeting Systems Its Ltd Oncology vaccine
CA3054871A1 (en) 2017-03-03 2018-09-07 Treos Bio Zrt Population-based immunogenic peptide identification platform
EP3370065A1 (en) 2017-03-03 2018-09-05 Treos Bio Kft Immunogenic peptides
EP3369431A1 (en) 2017-03-03 2018-09-05 Treos Bio Kft Vaccine

Also Published As

Publication number Publication date
AU2019334261B2 (en) 2025-04-10
WO2020048995A1 (en) 2020-03-12
CA3110923A1 (en) 2020-03-12
CO2021004028A2 (en) 2021-06-21
CN113383009A (en) 2021-09-10
EP3847185A1 (en) 2021-07-14
AU2019334261A1 (en) 2021-03-18
MX2021002543A (en) 2021-08-11
JP2025069437A (en) 2025-04-30
GB201814362D0 (en) 2018-10-17
JP2021535749A (en) 2021-12-23
CL2021000534A1 (en) 2021-09-24
IL281220A (en) 2021-04-29
US20220160854A1 (en) 2022-05-26
BR112021004075A2 (en) 2021-05-25
US20200069786A1 (en) 2020-03-05
KR20210086610A (en) 2021-07-08
EA202190669A1 (en) 2021-06-03
MA53544A (en) 2021-07-14
US20210236611A1 (en) 2021-08-05

Similar Documents

Publication Publication Date Title
IL281220A (en) Process for preparing vaccine compositions
IL276917A (en) Process for the preparation of elobixibat
IL274439A (en) Process for preparing tapinarof
SG11202010821TA (en) Vaccine composition
PL3894407T3 (en) Process for preparing apixaban
IL283331A (en) Method for preparing n-phenylpyrazole-1-carboxamides
HUE064356T2 (en) Process for preparation of enzalutamide using novel intermediate
IL268784B (en) Process for preparing bromotrichloromethane
SG11202009147UA (en) Vaccine compositions
HUE063118T2 (en) Process for the preparation of n-alkyl-nitratoethylnitramines
GB2562241B (en) Vaccine compositions
SG11202103389WA (en) Immunogenic compositions
PL3793985T3 (en) Process for preparing dioxolane
ZA201908452B (en) Improved process for preparing imetelstat
PL3793986T3 (en) Process for preparing dioxolane
GB201820754D0 (en) Methods for preparing compounds
SG11202002933TA (en) Compositions for booster vaccination against dengu
IL286006A (en) Process for preparing 4-amino-5-methylpyridone
GB201819292D0 (en) A process for preparing a formulation
HK40054255A (en) Process for preparing vaccine compositions
HUP1800278A2 (en) Process for the preparation of boc-linagliptin
GB201718251D0 (en) Vaccine Compositions
GB201400133D0 (en) Process for preparing confectionery composition
GB201906072D0 (en) Vaccine compositions
GB201809541D0 (en) Vaccine compositions